FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC March 7, 2022
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer March 18, 2014
Congratulations to Dr. Faye Johnson of the MD Anderson Cancer Center, the 2013 LCRF Scientific Merit Award Winner October 22, 2013